Login / Signup

Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease.

Mohamad Isam SaeedJosefin EklöfImane AchirPradeesh SivapalanHowraman MeteranAnders LøkkeTor Biering-SørensenFilip Krag KnopJens-Ulrik Staehr Jensen
Published in: Diabetes, obesity & metabolism (2020)
In patients with COPD, ICS use was associated with a moderate dose-dependent increase in the occurrence of type 2 diabetes.
Keyphrases
  • type diabetes
  • chronic obstructive pulmonary disease
  • lung function
  • risk assessment
  • cystic fibrosis
  • glycemic control
  • high intensity
  • cardiovascular disease
  • insulin resistance
  • air pollution